Table 4. Maximum adverse events by arm related to central nervous system depression.
| BAK (N=101) | Placebo (N=102) | |
|---|---|---|
| Confusion | ||
| None | 95 (95%) | 97 (97%) |
| Mild (1) | 5 (5%) | 2 (2%) |
| Severe (3) | 0 | 1 (1%) |
| Low consciousness | ||
| None | 98 (98%) | 98 (98%) |
| Moderate | 1 (1%) | 2 (2%) |
| Severe | 1 (1%) | 0 (%) |
| Constipation | ||
| None | 76 (76%) | 74 (74%) |
| Mild | 18 (18%) | 22 (22%) |
| Moderate | 5 (5%) | 4 (4%) |
| Severe | 1 (1%) | 0 (0%) |
| Rash | ||
| None | 84 (84%) | 90 (90%) |
| Mild | 11 (11%) | 6 (6%) |
| Moderate | 5 (5%) | 4 (4%) |
| Dry mouth | ||
| None | 83 (83%) | 78 (78%) |
| Mild | 17 (17%) | 22 (22%) |